» Articles » PMID: 29188437

Nasopharyngeal Carcinoma: Relationship Between Invasion of the Prevertebral Space and Distant Metastases

Overview
Date 2017 Dec 1
PMID 29188437
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To identify primary sites of nasopharyngeal carcinoma (NPC) invasion on the staging head and neck magnetic resonance imaging (MRI) that correlate with distant metastases (DM).

Materials And Methods: Staging head and neck MRI examinations of 579 NPC patients were assessed for primary tumour invasion into 16 individual sites, primary stage (T) and nodal stage (N). Results were correlated with distant metastasis-free survival (DMFS) using the Cox regression, and the diagnostic performance of significant independent markers for DM was calculated. In addition, sites of primary tumour invasion were correlated also with involvement of the first echelon of ipsilateral nodes (FEN+) using logistic regression.

Results: Distant metastases were present in 128/579 NPC patients (22.1%) after intensity-modulated radiotherapy (IMRT)/chemo-IMRT and 5-year DMFS was 78.8%. Prevertebral space invasion (PVS+) and N stage, but not T stage, were independent prognostic markers of DMFS (p = 0.016, < 0.001, and 0.433, respectively). Compared to stage N3, PVS invasion had a higher sensitivity (28.1 vs. 68.8%), but lower specificity (90.5 vs. 47.4%) and accuracy (76.7 vs. 48.9%) for correlating patients with DM. PVS invasion, together with parapharyngeal fat space invasion (PPFS+), was also an independent predictive marker of FEN+.

Conclusion: PVS was the only site of primary tumour invasion that independently correlated with DM, and together with PPFS + was an independent prognostic marker of FEN+, but the low specificity and accuracy of PVS invasion limits its use as a prognostic marker of DM.

Citing Articles

Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.

Wu B, Chen X, Cao C Curr Oncol Rep. 2025; .

PMID: 39998781 DOI: 10.1007/s11912-025-01651-9.


Nasopharyngeal carcinoma. A "different" head and neck tumour. Part B: treatment, prognostic factors, and outcomes.

Cantu G Acta Otorhinolaryngol Ital. 2023; 43(3):155-169.

PMID: 37204840 PMC: 10198365. DOI: 10.14639/0392-100X-N2223.


Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.

Nong S, Pan X, Chen K, Li Y, Zhu X Med Sci Monit. 2020; 26:e922244.

PMID: 32541642 PMC: 7315802. DOI: 10.12659/MSM.922244.


EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.

Chen S, Youhong T, Tan Y, He Y, Ban Y, Cai J Carcinogenesis. 2019; 41(6):723-733.

PMID: 31665243 PMC: 7351130. DOI: 10.1093/carcin/bgz180.

References
1.
King A, Lam W, Leung S, Chan Y, Teo P, Metreweli C . MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage. Br J Radiol. 2000; 72(860):734-41. DOI: 10.1259/bjr.72.860.10624338. View

2.
Lee A, Ma B, Ng W, Chan A . Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. J Clin Oncol. 2015; 33(29):3356-64. DOI: 10.1200/JCO.2015.60.9347. View

3.
Leung T, Tung S, Sze W, Wong F, Yuen K, Lui C . Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005; 27(7):555-65. DOI: 10.1002/hed.20189. View

4.
Lam W, Chan Y, Leung S, Metreweli C . Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck. 1997; 19(3):176-81. DOI: 10.1002/(sici)1097-0347(199705)19:3<176::aid-hed2>3.0.co;2-#. View

5.
Feng A, Wu M, Tsai S, Chan K, Cheng S, Wang A . Prevertebral muscle involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006; 65(4):1026-35. DOI: 10.1016/j.ijrobp.2006.02.012. View